News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Johnson & Johnson (JNJ) Could Get $5 Billion for Diagnostics Unit; Initial Bids Submitted



10/1/2013 7:14:24 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Johnson & Johnson (NYSE: JNJ) is on watch following reports that it might have received bids for its diagnostics unit. Reuters said late Monday that private equity firms like Blackstone Group LP (NYSE: BX), KKR & Co. (NYSE: KKR), Bain Capital LLC, Carlyle Group (Nasdaq: CG), and BC Partners Ltd. are among firms that have submitted first-round bids for J&J's Ortho Clinical Diagnostics unit. Market watchers suspect that the unit could ultimately draw $5 billion or more.

Help employers find you! Check out all the jobs and post your resume.

Read at Street Insider
Read at Reuters
Read at News Release
Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES